Is CSL Ltd (CSL) share price down?

CSL Ltd (CSL:ASX) set a new 52-week low during today's trading session when it reached 250.56. Over this period, the share price is down -9.05%. Data delayed at least 20 minutes, as of Sep 22 2023 05:11 BST. Latest CSL Ltd (CSL:ASX) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

What is CSL Behring & CSL Seqirus?

The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments.

What is CSL Behring & CSL Vidor?

The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology.

Is CSL a biopharmaceutical company?

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants.